Andrew Saik - Sep 21, 2023 Form 4 Insider Report for INTERCEPT PHARMACEUTICALS, INC. (ICPT)

Role
EVP & Chief Financial Officer
Signature
/s/ Rocco Venezia, as attorney-in-fact
Stock symbol
ICPT
Transactions as of
Sep 21, 2023
Transactions value $
-$9,806
Form type
4
Date filed
9/25/2023, 05:01 PM
Previous filing
Jun 23, 2023
Next filing
Nov 13, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICPT Common Stock Tax liability -$9.81K -908 -1.31% $10.80 68.3K Sep 21, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.